Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Neuhaus

Showing results (781-790 of 830) with videos related to

Pageof 83
Sort By:
Transplantation Proceedings|March 27, 2001
Donor pretreatment of grafts from marginal donors improves long-term graft outcomeA Reutzel-Selke, S G Tullius, T Zschockelt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2006
Improved long-term graft survival after HO-1 induction in brain-dead donorsK Kotsch, M Francuski, A Pascher, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 18, 2007
Transabdominal ligation of the thoracic duct as treatment of choice for postoperative chylothorax after esophagectomyG Schumacher, H Weidemann, J M Langrehr, et al.
Transplantation Proceedings|August 15, 2002
Immunosuppressive management following small bowel transplantationAndrea Raffaella Mueller, A Pascher, K-P Platz, et al.
Transplantation Proceedings|March 27, 2001
Improvement of long-term function in renal allografts from 'marginal donors' following the induction of heme-oxygenase-1S G Tullius, M Nieminen-Kelhä, A Reutzel-Selke, et al.
Transplantation Proceedings|March 27, 2001
Induction of heme-oxygenase-1 prevents ischemia/reperfusion injury and improves long-term graft outcome in rat renal allograftsS G Tullius, M Nieminen-Kelhä, U Bachmann, et al.
Transplantation Proceedings|September 2, 1998
Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantationM Glanemann, J M Langrehr, R Raakow, et al.
Transplantation Proceedings|September 2, 1998
Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantationS Jonas, O Guckelberger, W O Bechstein, et al.
Lancet (London, England)|September 1, 2000
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry studyR Adam, V Cailliez, P Majno, et al.
Transplantation|June 27, 2000
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trialP Neuhaus, J Klupp, J M Langrehr, et al.
Pageof 83

Showing results (781-790 of 830) with videos related to

Sort By:
Pageof 83
Transplantation Proceedings|March 27, 2001
Donor pretreatment of grafts from marginal donors improves long-term graft outcomeA Reutzel-Selke, S G Tullius, T Zschockelt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2006
Improved long-term graft survival after HO-1 induction in brain-dead donorsK Kotsch, M Francuski, A Pascher, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 18, 2007
Transabdominal ligation of the thoracic duct as treatment of choice for postoperative chylothorax after esophagectomyG Schumacher, H Weidemann, J M Langrehr, et al.
Transplantation Proceedings|August 15, 2002
Immunosuppressive management following small bowel transplantationAndrea Raffaella Mueller, A Pascher, K-P Platz, et al.
Transplantation Proceedings|March 27, 2001
Improvement of long-term function in renal allografts from 'marginal donors' following the induction of heme-oxygenase-1S G Tullius, M Nieminen-Kelhä, A Reutzel-Selke, et al.
Transplantation Proceedings|March 27, 2001
Induction of heme-oxygenase-1 prevents ischemia/reperfusion injury and improves long-term graft outcome in rat renal allograftsS G Tullius, M Nieminen-Kelhä, U Bachmann, et al.
Transplantation Proceedings|September 2, 1998
Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantationM Glanemann, J M Langrehr, R Raakow, et al.
Transplantation Proceedings|September 2, 1998
Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantationS Jonas, O Guckelberger, W O Bechstein, et al.
Lancet (London, England)|September 1, 2000
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry studyR Adam, V Cailliez, P Majno, et al.
Transplantation|June 27, 2000
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trialP Neuhaus, J Klupp, J M Langrehr, et al.
Pageof 83